(CXSE) China ex-State-Owned - Overview
Etf: Common Stocks, China, Non-State-Owned, Technology, Consumer
Dividends
| Dividend Yield | 2.03% |
| Yield on Cost 5y | 1.15% |
| Yield CAGR 5y | 16.23% |
| Payout Consistency | 90.1% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 23.7% |
| Relative Tail Risk | -7.41% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.25 |
| Alpha | 27.39 |
| Character TTM | |
|---|---|
| Beta | 0.664 |
| Beta Downside | 0.653 |
| Drawdowns 3y | |
|---|---|
| Max DD | 40.28% |
| CAGR/Max DD | 0.09 |
Description: CXSE China ex-State-Owned December 28, 2025
The WisdomTree China ex-State-Owned Enterprises Fund (NASDAQ: CXSE) aims to allocate at least 80 % of its net assets (excluding securities-lending collateral) to securities that either belong to its underlying index or closely replicate the index’s economic characteristics. The index is a modified float-adjusted market-cap weighted basket of Chinese common stocks that deliberately omits state-owned enterprises, making the fund “non-diversified” under U.S. regulations.
Key data points to note: the fund’s expense ratio is 0.65 %, its assets under management hover around US$ 1.2 billion, and the average daily trading volume exceeds $30 million, reflecting solid liquidity. Because it excludes SOEs, the portfolio is tilted toward privately-run sectors such as technology, consumer discretionary, and healthcare, which have collectively delivered a 12-month total return of roughly 15 % (as of Q3 2024). The fund’s performance is closely tied to China’s private-sector growth-GDP growth of 4-5 % YoY and ongoing policy support for innovation-driven firms are primary macro drivers.
For a deeper quantitative breakdown, you might explore the fund’s profile on ValueRay.
What is the price of CXSE shares?
Over the past week, the price has changed by -0.15%, over one month by +3.55%, over three months by -3.48% and over the past year by +39.62%.
Is CXSE a buy, sell or hold?
What are the forecasts/targets for the CXSE price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 45.1 | 7.5% |
CXSE Fundamental Data Overview January 28, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 502.3m USD (502.3m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 502.3m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 502.3m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 8.36% (E(502.3m)/V(502.3m) * Re(8.36%) + (debt-free company))
Discount Rate = 8.36% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)